The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Chromatin & Transcription | Molecular Biology of Disease
The EMBO Journal (2006) 25, 2453–2464, doi:10.1038/sj.emboj.7601106
Published online 4 May 2006
Absence of the steroid receptor coactivator-3 induces B-cell lymphoma
Agnès Coste1, Maria Cristina Antal2, Susan Chan1, Philippe Kastner1, 2, Manuel Mark1, 2, Bert W O'malley3 and Johan Auwerx1, 2
1 Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université Louis Pasteur, Illkirch, France
2 Institut Clinique de la Souris, Génopole Strasbourg, Illkirch, France
3 Department of Molecular and Cellular Biology, Baylor College of Medecine, Houston, TX, USA

To whom correspondence should be addressed
Johan Auwerx, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Parc d'Innovation, 1 rue Laurent Fries, BP10142, 67404 Illkirch, France. Tel.: +33 388 653425; Fax: +33 388 653201; E-mail: auwerx@igbmc.u-strasbg.fr

Received 24 November 2005; Accepted 29 March 2006; Published online 4 May 2006.
Abstract
Steroid receptor coactivator 3 (SRC-3/ACTR/AIB-1/pCIP/RAC3/TRAM-1) is a member of the p160 family of nuclear receptor coactivators that plays an important role in mammary gland growth, development, and tumorigenesis. We show that deletion of SRC-3 gene decreases platelet and increases lymphocytes numbers, leading to the development of malignant B-cell lymphomas upon aging. The expansion of the lymphoid lineage in SRC-3-/- mice is cell autonomous, correlates with an induction of proliferative and antiapoptotic genes secondary to constitutive NF-kappaB activation, and can be reversed by restoration of SRC-3 expression. NF-kappaB activation is explained by the degradation of IkappaB, consequent to increases in free IkappaB kinase, which is no longer inhibited by SRC-3. These results demonstrate that SRC-3 regulates lymphopoiesis and in combination with previous studies indicate that SRC-3 has vastly diverging effects on cell proliferation depending on the cellular context, ranging from proliferative and tumorigenic (breast) to antiproliferative (lymphoid cells) effects.
Keywords: cofactors, hematopoiesis, lymphoma, NF-kappaB, transcription
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

More negative feedback?

Nature Immunology News and Views (01 Jul 2003)

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2006 by the European Molecular Biology Organization